The ProDisc-C was developed using the same design principles as the ProDisc-L implant. The first ProDisc-C Total Disc Replacement surgery was performed in Europe in 2002. It was approved by the Food and Drug Administration (FDA) for use in the United States in December 2007.
A ProDisc-C IDE clinical study evaluated the ProDisc-C Total Disc Replacement surgery compared to spinal fusion surgery*. The study demonstrated that ProDisc-C surgery is a safe and effective alternative to fusion surgery* for qualified patients. For more information about the ProDisc-C IDE Study, refer to the ProDisc-C IDE Study Brochure and talk to your doctor.
For more information about the ProDisc-C implant and procedure, please refer to the resources provided on the right. This information is not a replacement for professional medical advice. Only your surgeon is qualified to diagnose and treat your condition.
*The ProDisc-C surgery was compared to an ACDF surgery, which involves removing the diseased disc and inserting a spacer into the space through an incision in the front of the nexk. A plate and screws are attached to the bones in the front of the spine to hold the spacer in place and to help promote fusion.